Review
doi: 10.1002/9781118105771.ch6.
Tissue transglutaminase and its role in human cancer progression
Affiliations
- PMID: 22220476
- DOI: 10.1002/9781118105771.ch6
Item in Clipboard
Review
Tissue transglutaminase and its role in human cancer progression
Adv Enzymol Relat Areas Mol Biol.
2011.
No abstract available
Similar articles
-
Structure and regulation of type 2 transglutaminase in relation to its physiological functions and pathological roles.Adv Enzymol Relat Areas Mol Biol. 2011;78:1-46. doi: 10.1002/9781118105771.ch1. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220471 Review. No abstract available.
-
Physiopathological roles of human transglutaminase 2.Adv Enzymol Relat Areas Mol Biol. 2011;78:47-95. doi: 10.1002/9781118105771.ch2. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220472 Review. No abstract available.
-
Transglutaminase 2 at the crossroads between cell death and survival.Adv Enzymol Relat Areas Mol Biol. 2011;78:197-246. doi: 10.1002/9781118105771.ch5. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220475 Review. No abstract available.
-
Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan.Adv Enzymol Relat Areas Mol Biol. 2011;78:385-414. doi: 10.1002/9781118105771.ch9. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220479 Free PMC article. Review. No abstract available.
-
Transglutaminase 2: a new paradigm for NF-kappaB involvement in disease.Adv Enzymol Relat Areas Mol Biol. 2011;78:161-95. doi: 10.1002/9781118105771.ch4. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220474 Review. No abstract available.
Cited by
-
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives.Onco Targets Ther. 2022 Mar 19;15:277-290. doi: 10.2147/OTT.S329262. eCollection 2022. Onco Targets Ther. 2022. PMID: 35340676 Free PMC article. Review.
-
Resting potential, oncogene-induced tumorigenesis, and metastasis: the bioelectric basis of cancer in vivo.Phys Biol. 2012 Dec;9(6):065002. doi: 10.1088/1478-3975/9/6/065002. Epub 2012 Nov 29. Phys Biol. 2012. PMID: 23196890 Free PMC article.
-
Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention.Mol Pharm. 2015 Jan 5;12(1):46-55. doi: 10.1021/mp500405h. Epub 2014 Dec 10. Mol Pharm. 2015. PMID: 25426679 Free PMC article.
-
Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity.Med One. 2018;3(6):e180011. doi: 10.20900/mo.20180011. Epub 2018 Nov 22. Med One. 2018. PMID: 30662957 Free PMC article.
-
TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway.Cell Cycle. 2019 May;18(10):1122-1134. doi: 10.1080/15384101.2019.1609831. Epub 2019 May 8. Cell Cycle. 2019. PMID: 31010374 Free PMC article.